Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constantine A Mantz

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Urology|February 16, 2010
Reduction in patient-reported acute morbidity in prostate cancer patients treated with 81-Gy Intensity-modulated radiotherapy using reduced planning target volume margins and electromagnetic tracking: assessing the impact of margin reduction studyHoward M Sandler, Ping-Yu Liu, Rodney L Dunn, et al.
Future Oncology (London, England)|December 20, 2014
The promise of combining radiation therapy and immunotherapy: morbidity and toxicityAndre M Agassi, Francisco A Myslicki, Jesse M Shulman, et al.
Cancer Control : Journal of the Moffitt Cancer Center|January 11, 2013
Building on sipuleucel-T for immunologic treatment of castration-resistant prostate cancerNeal D Shore, Constantine A Mantz, Daniel E Dosoretz, et al.
Clinical Genitourinary Cancer|December 3, 2014
Combining immunotherapy and radiation for prostate cancerSteven E Finkelstein, Sharon Salenius, Constantine A Mantz, et al.
International Journal of Radiation Oncology, Biology, Physics|January 7, 2021
Drivers of Medicare Spending: A 15-Year Review of Radiation Oncology Charges Allowed by the Medicare Physician/Supplier Fee-for-Service Program Compared With Other SpecialtiesMeriem Mokhtech, James H Laird, Sean Maroongroge, et al.
Brachytherapy|December 21, 2004
Endobronchial brachytherapy and optimization of local disease control in medically inoperable non-small cell lung carcinoma: a matched-pair analysisConstantine A Mantz, Daniel E Dosoretz, James H Rubenstein, et al.
Advances in Radiation Oncology|June 13, 2020
Gantry-Mounted Linear Accelerator-Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate CancerAudrey T Dang, Rebecca G Levin-Epstein, David Shabsovich, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2019
Multi-Institutional Analysis of Prostate-Specific Antigen Kinetics After Stereotactic Body Radiation TherapyNaomi Y Jiang, Audrey T Dang, Ye Yuan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 16, 2015
Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapyJoseph R Evans, Shuang Zhao, Stephanie Daignault, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2016
Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancerSkyler Bryce Johnson, Pamela R Soulos, Timothy D Shafman, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Urology|February 16, 2010
Reduction in patient-reported acute morbidity in prostate cancer patients treated with 81-Gy Intensity-modulated radiotherapy using reduced planning target volume margins and electromagnetic tracking: assessing the impact of margin reduction studyHoward M Sandler, Ping-Yu Liu, Rodney L Dunn, et al.
Future Oncology (London, England)|December 20, 2014
The promise of combining radiation therapy and immunotherapy: morbidity and toxicityAndre M Agassi, Francisco A Myslicki, Jesse M Shulman, et al.
Cancer Control : Journal of the Moffitt Cancer Center|January 11, 2013
Building on sipuleucel-T for immunologic treatment of castration-resistant prostate cancerNeal D Shore, Constantine A Mantz, Daniel E Dosoretz, et al.
Clinical Genitourinary Cancer|December 3, 2014
Combining immunotherapy and radiation for prostate cancerSteven E Finkelstein, Sharon Salenius, Constantine A Mantz, et al.
International Journal of Radiation Oncology, Biology, Physics|January 7, 2021
Drivers of Medicare Spending: A 15-Year Review of Radiation Oncology Charges Allowed by the Medicare Physician/Supplier Fee-for-Service Program Compared With Other SpecialtiesMeriem Mokhtech, James H Laird, Sean Maroongroge, et al.
Brachytherapy|December 21, 2004
Endobronchial brachytherapy and optimization of local disease control in medically inoperable non-small cell lung carcinoma: a matched-pair analysisConstantine A Mantz, Daniel E Dosoretz, James H Rubenstein, et al.
Advances in Radiation Oncology|June 13, 2020
Gantry-Mounted Linear Accelerator-Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate CancerAudrey T Dang, Rebecca G Levin-Epstein, David Shabsovich, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2019
Multi-Institutional Analysis of Prostate-Specific Antigen Kinetics After Stereotactic Body Radiation TherapyNaomi Y Jiang, Audrey T Dang, Ye Yuan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 16, 2015
Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapyJoseph R Evans, Shuang Zhao, Stephanie Daignault, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2016
Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancerSkyler Bryce Johnson, Pamela R Soulos, Timothy D Shafman, et al.
Pageof 3